PRISYM ID, a leading provider of data-led label and artwork management solutions used across medical device, clinical trial and pharmaceutical organizations, has been identified as the UK’s best-performing scale-up technology company in the government and healthcare software category of the Megabuyte Emerging Stars Awards.
The Awards are part of the Megabuyte100 series which collectively celebrates the 100 best performing technology companies in the UK. Megabuyte is the leading source of independent data and insights on UK technology and tech-enabled businesses, analyzing the financial and corporate strategy of some 2,000 companies.
This is the third win for PRISYM ID in this category, with the judges assessing the company’s performance against five key financial KPIs. For 2020, the judges acknowledged PRISYM ID’s success in building market share in the clinical trials market and indicated that overall, the business seems positioned for further growth.
Warren Stacey, SVP of Sales at PRISYM ID, said: “Our label and artwork management software designed for regulatory compliance, plays a vital role for many of the leading organizations in clinical trials and wider healthcare. We help them to maintain regulatory compliance and to manage devices, medicines and trials in the safest and most effective way.
“Our growth in areas such as clinical trials has been recognized by Megabuyte and it’s particularly gratifying that the team’s efforts have helped secure best performing company for a third time.”